



Title of Thesis                                      EFFECTS OF ANTHOCYANIN RICH   
                                                               EXTRACTS ON MULTIPLE BIOMARKERS  
                                                               OF COLON CANCER 
                                                               Geeta Lala  
                                                               Master of Science, 2005  
Thesis directed by:                              Assistant Professor Bernadene A. Magnuson 
                                                               Department of Nutrition and Food Science  
                                                                        
The aim of this study was to investigate the chemoprotective activity of anthocyanin-rich 
extracts (AREs) from bilberry (Vaccinium myrtillus), chokeberry (Aronia meloncarpa) 
and grape (Vitis vinifera) by assessing multiple biomarkers of colon cancer in rats treated 
with a colon carcinogen, azoxymethane.  Male F344 rats (n = 40) were fed AIN-93 diet 
(control) or AIN-93 diet supplemented with AREs for 14 weeks. Biomarkers evaluated 
included total aberrant crypt foci (ACF) that were reduced in ARE diet groups as 
compared to the control group. The number of large ACF and colonic cellular 
proliferation were decreased in rats fed bilberry and chokeberry ARE diets. Rats fed 
bilberry and grape ARE diets had lower COX-2 mRNA levels expression. Increased 
levels of fecal anthocyanins, fecal mass and moisture occurred in ARE-fed rats. 
Significant reduction of fecal bile acids was observed in ARE-fed rats. The results from 
this study suggest a protective role of AREs in colon carcinogenesis, and indicate 
multiple mechanisms of action are involved. 
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Chapter 1: Literature review 
1.1. Introduction  
Cancer, a disease resulting from deregulated cell growth control, is caused by the 
interaction of dietary, genetic, and environmental risk factors. Dietary factors are 
considered to play a major role in cancer etiology. It has been estimated that potential for 
cancer prevention by a healthy diet and lifestyle is excellent and might reduce the burden 
of frequently occurring cancers of the breast, prostrate and colon by 33-55%, 10-20% and 
66-75%, respectively (1). 
Colorectal cancer is the third most common and the third leading cause of cancer 
related mortality in the United States (2). It is estimated that approximately $8.4 billion is 
spent in the United States each year on treatment of colorectal cancer (3). In Maryland 
even though the knowledge regarding colorectal cancer screening is high (92%) colon 
cancer is still second leading cause of cancer (4). Several epidemiological and laboratory 
studies suggest a strong relationship between colon cancer risk and dietary factors (5-7). 
There is increasing evidence that risk is increased by high intakes of meat and fat, and 
that risk is decreased by high intakes of fruits and vegetables, and dietary fiber (8, 9). 
This field of investigation is nevertheless very confusing, particularly because 
longstanding hypotheses, such as the presumed protective effects of fruits, vegetables, 
and fiber, have recently been challenged by well-designed prospective trials. The search 
for individual components in the diet that convey protection persists (10).  
Anthocyanins are natural pigments that provide intense purple to red color in 
many fruits and vegetables such as blueberries, grapes, red cabbages and purple corn. 
Epidemiological investigations have indicated that moderate consumption of 
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anthocyanins through intake of products such as red wine (11) or bilberry extract (12) is 
associated with lower risk of cardiovascular disease and improvement of visual functions. 
In recent years, considerable studies have exhibited the ability of anthocyanins to inhibit 
oxidative stress (13, 14) and to induce apoptosis in malignant cells (15, 16) which both 
suggest that anthocyanins may prevent carcinogenesis.  
 
  Anthocyanin fractions extracted from different sources, including flower petals 
(17), grape rinds and red rice (18), red soybeans and red beans (19), Vaccinium species 
(20), different cherry and berry extracts (14), have demonstrated anticancer activity.  
In vitro, anthocyanin fractions more effectively inhibited growth of human intestinal 
carcinoma HCT-15 cells than did flavonoids (19). HCT116 colon cancer cells were 
inhibited by anthocyanin-containing berry extracts including cowberry, strawberry, 
blueberry, and bilberry extracts (21). Similarly, tart cherry anthocyanins and their 
aglycon cyanidin were shown to inhibit the growth of human colon cancer cell lines HT-
29 and HCT116 (22). In vivo, the tart cherry extract inhibited the intestinal tumor 
development in Apc(min) mice (22), suggesting that anthocyanins may reduce the risk of 
intestinal cancer. Freeze-dried black raspberries (23), purple corn (24), purple sweet 
potato and purple cabbage (25)  have been shown to inhibit azoxymethane-induced colon 
tumors in rats. 
 To further understand the role of anthocyanins as potential chemopreventive 
agents, Zhao et al. (26) previously investigated the chemopreventive activity of 
commercially available anthocyanin-rich extracts (AREs) of bilberry, chokeberry and 
grape in vitro in colon cancer cell lines. It was reported that AREs from bilberry, grape 
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and chokeberry exhibited different anthocyanin profiles and were able to significantly 
inhibit growth of human colon cancer cells, HT-29 with little effect on growth of non-
transformed colon epithelial cells, NCM460 (26, 27). Further investigation demonstrated 
that chokeberry ARE inhibited growth and cell cycle progression in colon carcinoma 
cells mainly through up regulation of p21WAF   and p27 kip1 genes and down regulation of 
cyclin A and cyclin B1 genes (27).  
 
1.2. Colorectal Cancer 
1.2.1. Introduction 
Intestinal tumors develop from epithelial cells lining the crypts and villi. It is 
considered through several observations that food passes through the small intestine 
much faster than large intestine. This may account, in part, for the 50 times lower 
incidence of tumors in jejunum and ileum than in colon and rectum. The recto sigmoid 
area, where feces are retained the longest, is the most common site of intestinal cancer in 
humans (28).  
Other risk factors that have been correlated with the etiology and pathogensis of 
colon cancer are increasing age, family history, genetic factors such as Familial 
Adenomatous Polyposis (FAP) or Gardner’s syndrome, inflammatory bowel disease like 
ulcerative colitis, and Crohns disease (28).  
Death rates for colorectal cancer for each race/ethnicity are approximately 40% 
higher among men than women. Blacks had the highest death rate for colorectal cancer, 
followed by whites. Death rates for colorectal cancer have decreased 2.2% per year for 
white men and 1.8% per year for white women. Declines in death rates among black men 
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and women were approximately 50% less than that for whites (2), Until age 50, men and 
women have similar incidence of mortality rates, after age 50 men are more vulnerable 
(3). 
 
Almost 95 percent of malignant colorectal tumors are adenocarcinoma, and 
remaining 5 percent compromise of carcinoids, sarcomas and lymphomas (28). 
Adenomas are lumps of epithelial dysplasia, which are classified into three major 
histological types: tubular, villous and tubulovillous. An adenoma is considered 
malignant and becomes an adenocarcinoma, when there is evidence that neoplastic cells 
pass through the muscularis mucosae and infiltrate the submucosa (28). After crossing 
the submucosa, the local invasion of neoplastic cells and potential for metastasis is 
possible. Adenomas show different grades of dysplasia, degree of severity and these 
abnormalities are graded into mild, moderate and severe dysplasia. Colorectal carcinoma 
can be graded into well-differentiated, moderately differentiated and poorly differentiated 
lesions. The more poorly differentiated lesions are more advanced and have poorest 
prognosis (28,29).  
 
1.2.2. Multistage Progress of Colon Carcinoma 
Colorectal carcinogenesis is a complex multistage process. The multistage 
progression requires years and possibly decades to develop from normal tissue to 
invasive cancer.  The process is accompanied by a number of genetic and cellular 
alterations. The genetic pathway model for the pathogenesis of sporadic colorectal cancer 
was proposed by Fearon and Vogelstein (30,31). This model of colorectal carcinogenesis 
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was proposed over 10 years ago.  Since that time, other mutations that occur at a high 
frequency in colorectal cancer have been identified, and the original model has been 
considerably elaborated to take in account the alternative pathways for the development 
of cancer that are now known to exist (29).   
Mutations in two classes of genes, tumor-suppressor genes and proto-oncogenes, 
are thought to impart a proliferative advantage to cells and contribute to development of 
the malignant phenotype. Inactivating mutations of both copies (alleles) of the 
adenomatous polyposis coli (APC) gene, a tumor-suppressor gene on chromosome 5q 
mark one of the earliest events in colorectal carcinogenesis (32). Germline mutation of 
the APC gene and subsequent somatic mutation of the second APC allele cause the 
inherited FAP syndrome. Mutation leading to dysregulation of the K-ras protooncogene 
is also thought to be an early event in colon cancer formation (32). After initiation, the 
transition from adenoma to carcinoma or high-grade dysplasia (HGD) appears to involve 
tumor suppressor genes, like tumor protein 53 (TP53), that are considered guardians of 
the genome. Once HGD occurs it has been suggested that genetic chaos ensues setting the 
stage for malignant transformation (33).  The goal of cancer prevention studies is to 
either prevents the initiation of, or to slow or stop the process of, cancer development at 
as early a stage as possible, as the more progressed the tumor, the less responsive to 
prevention or treatment strategies. Therefore, the use of early biomarkers of colon cancer 
in prevention studies will be reviewed. 
 
The multistage process of carcinogenesis has also given rise to the idea that the 
real target for initiation is in a stem cell population (34). Stem cells are considered to 
   - 5 -  
have innate capacity for long-term proliferation and the ability to differentiate along 
several directions. In the large intestine, the stem cell population is thought to exist near 
the base of crypts (35). The progeny of stem cells migrate up the crypt, continuing to 
divide until they reach the mid portion where the cells stop dividing and instead begin to 
differentiate to mature cells. When differentiated cells reach the top of the crypt, they 
undergo apoptosis and are engulfed by stromal cells or shed into the lumen. It was 
considered that neoplastic cells within early neoplasm are derived from stem cells at the 
base crypts and such cells should give rise to new, completely dysplastic crypts that 
branch as the lesions expand. However the development and morphogensis of the 
adenomatous polyp is still a topic of further research.  
  
Regarding successful strategies of diet intervention studies, it has been suggested 
that animal studies are important as a necessary preliminary stage before expensive 
human studies are attempted (36). This is especially relevant for colorectal cancer 
prevention due to the multistage nature of carcinogenesis. It is imperative to know and 
understand the point of action in the carcinogenesis process, as well as to identify 
appropriate dosing of cancer preventive agent before designing definitive human 
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1.3. Biomarkers of colon cancer in animal model 
Chemical carcinogen- induced rodent models are well accepted and widely used 
for the study of potential colon cancer chemopreventive agents. Macroscopic colon 
tumors in rodents have been considered an  endpoint marker for many years but due to 
some practical drawbacks of these studies such as requiring a large group of rodents, the 
long time period required for tumors to develop (up to 8-9 months) and time-consuming 
histological procedure for confirmation of the tumors, alternative markers for colon 
cancer are now being developed and validated (37).  
1.3.1 Aberrant crypt foci  
Abberant crypt foci (ACF) are considered precancerous lesions of colorectal 
cancer, and are recognized in the colonic surface of rats treated with colon specific 
carcinogens like azoxymethane (AOM) (38).  ACF have an increased proliferative 
activity and some reveal histopathological dysplasia. They are defined as crypts that have 
(i) altered luminal openings, (ii) exhibit thickened epithelia,  (iii) are larger than adjacent 
normal crypts and (iv) are microscopically elevated (39) (Fig.1A and B). The use of the 
ACF system to study modulators of colon carcinogenesis has accelerated for the last 10 
years, for it provides a simple and economical tool for preliminary screening of potential 
chemopreventive agents. In a systematic review of ACF and tumor data, Corpet et al. 
reported significant correlation of the potencies of 57 chemopreventive agents to inhibit 
ACF and to inhibit colon tumors. The presence of ACF has also been shown to correlate 
with colon cancer risk and adenoma size and number in humans (40). Therefore ACF are 
now regarded as a surrogate end point for tumors in rats and human intervention trials. 
 









Fig. 1A. Topographic view of two ACF in a rat exposed to AOM. Each Focus has 6-7 
crypts, which are much larger than the surrounding normal crypts. Methylene blue 
staining of colon facilitates identification. 
 
 
(Adapted from H. Mori et al 2004.) 
 
                                               
 
 
Fig 1B. Endoscopic features of ACF in patients with adenomas. Methylene blue 
staining reveals a small focus consisting of three crypts with semicircular or oval 
lumens). The aberrant crypts stain more darkly, are larger, and have a thicker 




(Adapted from T.Takayamya et al. 1998)
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1.3.2. Cell proliferation 
 
Cell proliferation is considered to play an important role in different stages of 
multistage carcinogenesis.  In proliferating tissues, various genetic changes progressively 
accumulate and clonal proliferation of genetically damaged cells leads to the formation of 
foci, nodules and then to tumors that can escape from the control of neighboring cells 
(41). Abnormal patterns of cell proliferation in the entire colonic mucosa of patients with 
colonic adenoma or carcinoma and also in patients with heredity disposition to colorectal 
cancer (e.g. FAP) have been reported (42). In the colon, the mucosal cell proliferation, 
which is normally restricted to the stem cell zone, extends to the entire crypt during 
carcinogenesis and leads to formation of ACF, polyps, adenomas and carcinomas. In a 
review of different dietary endpoint markers, Rafter et al. (37) consider nutritional 
inhibition of cell proliferation as a valuable surrogate marker. The inhibition is 
considered to be beneficial in both colon cancer prevention and tumor therapy. 
Measurement of proliferation biomarkers utilizes immunohistochemistry. These methods 
are considered relatively simple, reliable and suited for large number of specimens (43).   
Two commonly used antibodies are Ki67 and proliferating cell nuclear antigen 
(PCNA). They both are nuclear proteins whose level varies as a function of the cell cycle. 
PCNA, which has been used in this study, is an auxillary protein to polymerase delta and 
is expressed during G1 phase of cell cycle (44). 
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1.3.3. Cyclooxygenase 1 and 2 
Cycoloxygenase (COX) catalyzes a key step in conversion of arachidinoic acid to 
prostaglandins (PGs) (45). PGs have important functions in almost every organ system 
and regulate such diverse physiological processes as immunity, reproduction, 
maintenance of vascular integrity and bone metabolism (46). There are two known 
isoforms of COX that differ in their tissue distribution and regulation. COX-1 is 
responsible for housekeeping PG biosynthesis and is constitutively expressed in most 
tissues in the body. COX-2 is not normally expressed in most tissues but is induced by a 
wide spectrum of growth factors and proinflammatory cytokines in specific 
pathophysiological conditions (46). COX-2 is over-expressed in many cancers including 
esophagus, stomach, colon, lung, pancreas head and neck (47). 
Direct evidence implicating COX-2 in colorectal carcinogenesis comes from a 
mouse model Apc∆716, in which there is a knockout of the COX-2 gene. The number 
and size of intestinal polyps was reduced in these mice compared with COX wild type 
mice (48). Ebhart et al. (49) documented for the first time significant elevation in COX-2 
expression in 85% of human colorectal carcinomas and approximately 50% of colorectal 
adenomas. COX-2 is also over-expressed in adenomas of Apcmin mice (50) and 
carcinoma samples from the colon of AOM – treated rats (51). Inhibition of COX-2 
activity is considered a valuable surrogate marker of chemoprevention. There is 
significant evidence from non-steroid inflammatory drugs (NSAIDS) that COX-2 
inhibitors are effective at suppressing the growth of established colorectal tumors (52). 
Although the effect of diet on COX-2 inhibition is less explored, it is considered that 
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dietary components that can inhibit the expression of COX-2 may be important for 
inhibiting tumor development in the colon (37). 
 
1.3.4. Fecal bile acids 
    Evidence drawn from a large number of observations in animal and human trials 
support an important role of fecal bile acids (FBA) in colon carcinogenesis. In animal 
models, the bile acid, cholic acid acts in the promotion phase of carcinogenesis. 
Furthermore, bile acid increases colonic epithelial proliferation (53). The bile acid, 
deoxycholic acid was proposed to be carcinogen in 1939 and 1940 (54). On the basis of 
later work with rodent models, bile acids came to be regarded as cancer promoters rather 
than carcinogens (55). However, considerable evidence obtained more recently again 
supports the view that bile acids are carcinogens in humans for gastrointestinal cancer 
(54). Epidemiological studies have found that fecal bile acid concentrations are elevated 
in populations with a high incidence of colon cancer (55). 
 
The mechanisms by which bile acids promote colon carcinogenesis are not 
completely understood. The secondary bile acids deoxycholic acid and chenodeoxycholic 
acid have been reported to be cytotoxic to colonic epithelial cells, moderately mutagenic, 
associated with dysplastic changes (56), and to be antiapoptotic (57). Dietary intake of 
calcium lowers the incidence of cancer. Calcium supplements in the presence of 
phosphate removes bile acid from solution and decrease their interaction with colon 
epithelium (58). In human studies, high intake of dietary fat that correlates with increased 
colon cancer risk, results in increased FBA concentration whereas wheat barn, which 
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negatively correlates with colon cancer, reduces FBA concentration (37, 59, 60). 
However, to date there is no literature reporting the effect of dietary anthocyanins on 
fecal bile concentrations. 
 
1.4. Dietary intervention in prevention of colon cancer  
Different stages of colorectal cancer can be modulated by dietary factors, which 
directly interact with gene expression or modulate key enzymes activities involved in cell 
proliferation and differentiation (37). A large number of studies have provided evidence 
that there is an inverse relationship between colorectal cancer and consumption of plant 
foods (61). One explanation for this relationship is that vegetables, fruits and whole 
grains contain a wide variety of phytochemicals (like terpenes, isothiocyanates, 
caretenoids, and flavanoids), which have potential to modulate cancer development (10).  
Flavonoids are plant secondary metabolites, present in all terrestrial vascular plants, with 
a wide variety of beneficial biological properties such as anticarcinogenic and 
antioxidative modes of action (62). In this study, one class of flavonoids, anthocyanins, 
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1.5. Anthocyanins  
Anthocyanins are one class of flavonoid compounds that are truly pigments  and 
produce great range of colors from scarlet to blue (63)  Flavonoids are plant secondary 
metabolites, present in all terrestrial vascular plants with a wide variety of beneficial 
biological properties such as anticarcinogenic and antioxidative modes of action (62). 
Anthocyanins are also considered powerful dietary antioxidants.  It has been estimated 
that human intakes of anthocyanins are between 180 and 215 mg/day in the US, which is 
much higher than the intake of other known flavonoids. The daily intake of flavanoids 
including quercetin, myricetin, and kaempferol, luteolin and apigenin is estimated to be 
only 20-22 mg/day in the US (64).  
 
  
1.5.1 Chemical structure  
Anthocyanins show high diversity and are an important group of water-soluble 
pigments in nature (63, 65). The word anthocyanin is derived from two Greek words 
anthos, which means flower, and kyanos, which means dark blue, revealing their 
important characteristic as natural colorants. Their contribution to the colorful appearance 
of fruits, vegetables and flowers help them to attract animals, leading to seed dispersal 
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1.5.2. Basic Structure 
The range of Anthocyanin is represented by infinity of natural colors produced by 
the chemical combination of the basic C-6-C-3-C-3 (phenyl-2-benzopyrilium) 
anthocyanindin structure (Fig. 2). Anthocyanin structure is complemented by one or more 
sugar molecules bonded at different hydroxylated, positions of basic structure. Thus 
anthocyanins are substituted glycosides of salts of phenyl-2-benzopyrillium 
(anthocyanidins). Their diversity is associated with number of sugar molecules in their 
structure and also by chemical combination of these sugars with organic acids. Moreover 
the number of hydroxyl and methoxyl groups attached to the basic 3 ring structure affects 
color of anthocyanins, i.e. if more hydroxyl groups are present, then the color is more 















Figure 2.: Basic structure of anthocyanidin pigment  (flavylium cation). Rx could be 
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1.5.3. Glycosylation and Acylation 
To obtain an anthocyanin, the anthocyanidin (also called aglycon) is glycosylated 
by one or more sugar molecule. Thus anthocyanins are also known by the number of 
sugar molecules in their structures (e.g. monosides, biosides, triosides) (63).  Glucose, 
galactose, rhamnose and arbinose are the sugars most commonly encountered (66). The 
stability of anthocyanins is enhanced by one or more sugar molecules bonded at different 
hydroxyl positions. With a few exceptions anthocyanins are always glycosylated at C-3 
(67).  Diversity is further increased by the chemical combination of these sugars with 
organic acids to produce acylated anthocyanins (63). Common acylating agents include 
cinnamic acid derivatives such as caffeic, p-coumaric, ferulic and sinapic acid as well as 
a range of aliphatic acids such as acetic, malic, malonic, oxalic, and succinic acid. Since 
each anthocyanidin may be glycosylated and acylated by various sugars and acids at 
different positions, a great number of chemical combinations exist. (63) 
Based on several reviews, it was estimated that more than 600 anthocyanins had 
been found in nature (68). Such tremendous variations, together with the pH-dependent 
and chelating metal ion-dependent color change (69), are responsible for the amazing 
array of natural colors from anthocyanins. 
 
 
1.5.4. Daily intake, absorption, and metabolism 
In US, average daily intake of anthocyanins has been estimated at 215 mg during 
summer and 180 mg during winter. It has been suggested that regular consumers of red 
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wine are likely to have significantly higher intakes since the concentration of 
anthocyanins in red wines is in the range of 240-350 mg/litre (66, 70).  
The various studies done in humans have suggested low bioavailability of 
anthocyanins as indicated by very low recovery in the plasma and urine after ingestion 
(71, 72).  Single doses ranging from 150 mg to 2 g total anthocyanins were given to the 
volunteers generally in the form of berries, berry extracts or concentrates. After such 
intakes, concentrations of anthocyanins measured in plasma were very low, in the order 
of 10-50 nmol/l and in some studies they were below the detection limit. The mean time 
to reach Cmax was 1.5 h (range: 0.75–4 h) for plasma and 2.5 h for urine. Most studies 
reported low relative urinary excretions, ranging from 0.004% to 0.1% of the intake, 
although Lapidot et al. (73) and Felgines et al. (74) measured higher levels of 
anthocyanin excretion (up to 5%) after red wine or strawberry consumption. The time 
course of absorption was consistent with absorption in the stomach, as described for 
animals (75,76). The prominent feature of these studies is considered to be that 
anthocyanins are very rapidly absorbed and eliminated, and that they were absorbed with 
poor efficiency (77).  
 
Recent studies (78) in rats measured plasma levels of anthocyanins after oral 
supplementation with blueberry skin extract containing cyandin-3 (Cy-3) galactoside, 
cyandin-3 glucoside (C3G), Cy-3 arbinoside and the aglycon, cyandin. The results 
indicated that cyandin glycosides are absorbed from the digestive tract to the blood 
stream in their intact glycosylated forms. These results were in agreement with a pervious 
report by Tsuda et al. (79) on cyandin –3-O-β-glucosides (C3G).   In this study rats were 
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orally administered C3G (0.9 mmol/kg body weight), and C3G rapidly appeared in the 
plasma. However, the aglycon of C3G (cyanidin; Cy) was not detected, although it was 
present in the jejunum. Protocatechuic acid (PC), which may be produced by degradation 
of Cy, was present in the plasma and the concentration was 8-fold higher than that of 
C3G. In the liver and kidney, C3G was metabolized to methylated C3G (methyl-C3G), 
suggesting that C3G and/or methyl-C3G act as antioxidants in the tissues.  
Miyazawa (80) and Matsumoto et al. (81) also showed that cyandin glycosides 
were detected in unaltered forms in blood of both rats and humans after oral 
administration of black currant (mainly containing C3G and Cy-3,5-diglycoside) or 
elderberry juices (primarily composed by Cy-3-O-β-rutinoside).  
 
 In two studies with rats, Tsuda and co-workers (13) also suggested that C3G is 
partly hydrolyzed by the β-glycosidase reaction in the intestines, thus explaining the 
detection of the aglycon in the jejunum. No detection of the aglycon in the plasma was 
related to cyanidin instability in plasma and its consequent massive degradation to 
protocatechuic acid.   
Seeram et al. (82) confirmed that protocatechuic acid was the predominant 
degradation product of cyanidin in a cell culture study.  
 
Another study to assess the metabolism of C3G was performed by Stumpf et al. 
(83). They used an isolated perfused rat small intestinal preparation. Results confirmed 
that C3G was absorbed into the vascular effluent and incorporated into intestinal tissue, 
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whereas the aglycone cyanidin was not detectable. They also reported detection of 
glucuronate and sulfate conjugates of C3G as intestinal metabolites.  
Animal studies have identified some metabolites of anthocyanins but in a recent 
review, Manach et al. (77) suggested that based on our current knowledge, there are 
important differences in the metabolism of anthocyanins, as compared with other 
polyphenols. Therefore further research for the analysis of metabolites of anthocyanins 
should be performed. 
 
1.6.  Role of anthocyanins in maintaining health  
 
Anthocyanins are implicated in many biological activities that may impact 
positively on health (84).  Their use for therapeutic purposes has long been supported by 
both anecdotal and epidemiological evidence, but only in recent years some of the 
specific, measurable pharmacological properties of isolated anthocyanin pigments have 
been conclusively verified by rigorously controlled in vitro, in vivo, or clinical research 
trials (84).These pigments may reduce the risk of coronary heart disease through 
modulation of arterial vasomotion (85) inhibition of platelet aggregation (86) or 
endothelial protection (87). In addition, anthocyanins could exert anticarcinogenic 
activities, reduce inflammatory insult and also modulate immune response. All these 
effects might be mediated by their antioxidant activity (69).  
 
In many other cases, the exact roles of the anthocyanins in human health 
maintenance versus other phytochemicals in a complex mixture from a fruit extract or 
whole food have not been completely sorted out. In fact, some reports suggest that 
anthocyanin activity potentates when it is delivered in mixtures (88, 89).  
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Visual acuity can be markedly improved through administration of anthocyanin 
pigments to animal and human subjects, and the role of these pigments in enhancing 
night vision or overall vision has been particularly well documented (84).  Oral intake of 
anthocyanoside from black currants resulted in significantly improved night vision 
adaptation in human subjects (90)  and similar benefits were gained after administration 
of anthocyanins from bilberries (91).  
Tsuda et al. (92) recently provided evidence that anthocyanins extracted from 
purple corn, when provided to mice in combination with a high-fat diet, effectively 
inhibited increases in both body weight and adipose tissue. Typical symptoms of 
hyperglycemia, hyperinsulinemia, and hyperleptinemia provoked by a high-fat diet did 
not occur when mice also ingested isolated anthocyanins. The experiments suggest that 
anthocyanins, as a functional food component, can aid in the prevention of obesity and 
diabetes. 
Anthocyanins have been credited with capacity to modulate cognitive and motor 
function, to enhance memory, and to have a role in preventing age-related declines in 
neural function. Cho et al. (93)  reported that administration of isolated semipurified 
anthocyanins from purple sweet potato enhanced cognitive performance as assessed by 
passive avoidance tests in ethanol-treated mice, and also effectively inhibited lipid 
peroxidation in rat brain tissues. By administering blueberry extracts with significant 
anthocyanin content (but not purified pigments), it was noted that the blueberry-
supplemented diets led to effective reversal of age-related deficits in various neural and 
behavioral parameters (memory and motor functions) (94). Further investigations by this 
laboratory team demonstrated that anthocyanins (in particular, cyanidin-3-sambubioside-
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5-glucoside and cyanidin-3, 5-diglucoside) were highly bioavailable in endothelial cells, 
which was linked to their roles in prevention of atherosclerosis and neurodegenerative 
disorders (78, 94).  
Anthocyanins exerted multiple protective effects against pleurisy in a rat model 
and were capable of attenuating inflammation. Anthocyanin treatment also 
downregulated expression of enzymes involved in the inflammation of the lung (95).  The 
antimicrobial activity of anthocyanins in general has been well established, including 
significant inhibition of aflatoxin biosynthesis (96). The experimental evidence 
demonstrating anthocyanin benefits for diabetes and pancreatic disorders has also 
accumulated in recent years, and again the efficacy is attributed to the multiple, 
simultaneous biological effects these pigments cause in the body, including prevention of 
generation of free radicals, decreased lipid peroxidation, reduced pancreatic swelling, and 
decreased blood sugar concentrations in urine and blood serum (97, 98). 
 
1.7. Antioxidant properties of anthocyanin  
 
The antioxidant capacity of anthocyanins has been demonstrated with a wide 
variety of assay methods. Berry extracts demonstrated potent antioxidant activities that 
correlated with anthocyanin content (99, 100). Ferric reducing ability of plasma (FRAP) 
method used to reflect antioxidant activity showed that the 3-glucosides of delphidin, 
petunidin and malvidin were 2-2.5 times more potent antioxidants than ascorbic acid 
(101). The antioxidant capacity measured with oxygen radical absorbing capacity 
(ORAC) tests in Trolox equivalents absorbing capcity (TAEC) found anthocyanins to be 
3-6 fold that of standard antioxidant trolox (101,102) . According to Cooke et al. the 
structure-antioxidant pattern emerging from different studies indicates that potent 
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antioxidant activity is associated with presence of hydroxyl groups in the anthocyanin B-
ring. The antioxidant capacities of cyandin and cynadin 3- glucosides were similar to α –
tocopherol in assay systems of linolenic acid, liposomes, rabbit erythrocyte membranes 
and rat liver microsomes (103).  
 
 
1.8.  Anthocyanins and Colon Cancer  
Anthocyanidins and anthocyanins have been shown to inhibit the growth of 
embryonic fibroblasts and of cancer cells derived from malignant human tissues. Tissues 
originating from the central nervous system (CNS), lung, breast, prostrate uterus, vulva 
and colon have been investigated for the evidence of chemopreventive activity by 
anthocyanins. (104, 105). The studies linking the specific role of anthocyanins and colon 
cancer are small in number, but those conducted to date have provided consistent and 
convincing evidence of a protective effect.  
 
1.8.1 Effects of anthocyanin on colon cancer in vitro 
In vitro growth inhibition of human colon cancer cell lines HCT 15 (106) , HT-29 
(22) and HCT–116 (22) has been demonstrated by anthocyanin fractions.  Tart cherry 
anthocyanins and cyandin reduced cell growth of human colon cancer cell lines, HT29 
and HCT 116. The IC 50 (inhibitory concentration 50%) is the concentration required for 
50% inhibition of cell growth was measured for anthocyanins and cyandin. It was 780 
µM for tart cherry anthocyanins and 63 µM for cyandin in HT 29 cells. IC50 for HCT 
116 cells was 285 µM  for tart cerry anthocyanin and 85 µM for cyandin respectively 
(22).  
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Olsson et al. (99)  investigated the effects of 10 different extracts of fruits and 
berries on cell proliferation  of HT 29 colon cancer cells. The fruits and berries used were 
rosehips, blueberries, black currant, black chokeberries, apple, sea buckthorn, plum, 
lingonberries, cherries, and raspberries. The extracts decreased the proliferation of HT 29 
cells. The effect of inhibition was in range of 48-74% (average=62%) for HT 29 cells. 
The anthocyanin fraction of the extract of black chokeberries, apple, rosehips, raspberries 
and lingonberries decreased cell proliferation, whereas blueberries and cherries increased 
cell proliferation at the highest concentration. HT 29 cells were inhibited to lower extent 
than HCT 116 colon cancer cells. They also investigated other antioxidants present in 
these fruits and concluded that the synergistic effect of anthocyanin, vitamin C and to a 
certain extent, some caroteniods control cancer cell proliferation. The authors have also 
stated that sugar-conjugated anthocyanins are less effective than the aglycon, cyandin, in 
inhibiting the growth of HT 29 cells.  
In contrast to the above results, recent study done by Yi et al. (15) concludes that 
anthocyanins from blue berries can inhibit colon cancer cell proliferation. This study 
systematically evaluated the bioactivities of phenolic compounds in rabbiteye blueberries 
and assessed their potential antiproliferation and apoptosis induction effects using two 
colon cancer cell lines, HT 29 and Caco-2. Polyphenols in three blueberry cultivars, 
Briteblue, Tifblue, and Powderblue, were extracted and freeze-dried. The extracts were 
further separated into phenolic acids, tannins, flavonols, and anthocyanins. They found 
that the greatest antiproliferation effect among all four fractions was from the 
anthocyanin fractions. Both HT 29 and Caco-2 cell growth was significantly inhibited by 
>50% by the anthocyanin fractions at concentrations of 15-50 µg/mL. Anthocyanin 
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fractions also resulted in 2-7 fold increases in DNA fragmentation, indicating the 
induction of apoptosis. The effective dosage levels were close to the reported range of 
anthocyanin concentrations in rat plasma.   
The growth inhibitory effect of anthocyanins extracted from flower petals in 
HCT-15 cells colon carcinoma cells was greater than other flavonols and flavanones (17). 
Among ethanol extracts of 10 edible berries, bilberry extract was found to be the most 
effective at inhibiting the growth of HL60 human leukemia cells and HCT116 human 
colon carcinoma cells in vitro. Only pure delphinidin and the delphinidin glycoside 
isolated from the bilberry extract, but not malvidin and the malvidin glycoside, inhibited 
the growth of HCT116 cells (21).  
In an earlier study, Kamei et al. (106) investigated the anti-tumor effect of crude 
methanol extracts of red and white wines on colon and gastric cancer cells.  Extracts were 
added to diethyl ether in order to divide them into the anthocyanin fraction (insoluble in 
diethyl ether) and fractions containing other flavonoids and their derivatives (soluble in 
diethyl ether). The white wine did not contain anthocyanins (all of the methanol extract 
was soluble in diethyl ether). HCT-15 cells, derived from human colon cancer, or AGS 
cells, derived from human gastric cancer, were cultured with these fractions. The 
anthocyanin fraction from the red wine and the non-anthocyanic substances extracted 
from red and white wines suppressed the growth of the cells, and the suppression rate by 
the anthocyanin fraction was significantly higher than that of the other fractions. 
Anthocyanin fractions from red soyabeans and red beans inhibited growth of 
HCT–15 human colon carcinoma cells (19). In a recent study by Yi et al. (107), phenolic 
compounds were extracted from muscadine  grape skins and were further separated into 
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phenolic acids, tannins, flavonols, and anthocyanins. The greatest inhibitory activity was 
also found in the anthocyanin fraction, with a 50% inhibition at concentrations of 
approximately 200 µg/mL in HT-29 and 100-300 µg /mL in Caco-2 cells respectively. 
Anthocyanin fractions also resulted in 2-4 times increase in DNA fragmentation, 
indicating the induction of apoptosis. These studies demonstrate anthocyanin potential 
usefulness as colon cancer chemopreventive agent.  
1.8.2 Effects of anthocyanin on colon cancer in vivo 
In vivo, anthocyanin-containing mixtures have shown colon cancer 
chemopreventive activity in rats and Apc Min mice. Apc Min mice carry an APC gene 
mutation. They develop adenomas in the small intestine tract and are considered to 
reflect, in many respects, human familial adenomatous polyposis coli (FAP) syndrome 
(108). In a comparative investigation done by Kang et al. (22), Apc Min mice received 
either a mixture of anthocyanins at 800 mg/l or pure cyandin at 200 mg/l with drinking 
water or tart cherries added to the diet (200 g/kg diet). These amounts correspond to 
doses of approximately 2.4 and 0.6 mg anthocyanins/animal/day or 600 mg of tart 
cherries/animal/day, respectively based on average daily intake of diet and water. Mice 
that received these interventions had significantly fewer and smaller cecal adenomas than 
mice consuming the control diet or non-steroidal inflammatory drug sulindac. However, 
no significant effect was observed on colon tumors, possibly due to the low number of 
colon tumors that develop in this model.  
A recent study by Cooke et al. (104) suggested a moderate but significant 
reduction in small intestinal adenoma number in Apc Min that received either an 
anthocyanin-containing blueberry extract or pure cyandin –3-glucoside at 0.1% (w/w) in 
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their diet. This concentration was considered to be approximately a dose of 3.0 mg 
anthocyanin/mouse/day. 
Purple sweet potato (PSP), red cabbage and purple corn color (PCC), which are 
rich in anthocyanins, have also been shown to inhibit chemically-induced carcinogenesis 
in male F344/DuCrj rats, initially treated with 1,2-dimethylhydrazine (DMH) (24, 25). 
After DMH initiation, rats ingested PSP, red cabbage or PCC colorings at doses 
approximately 490, 620 and 233 mg anthocyanins/rat/day, respectively along with 0.02% 
2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) in the diet until week 36. The 
incidence and multiplicity of colonic adenomas and adenocarcinomas were significantly 
decreased in all dose groups as compared to control rats. The PCC and red cabbage also 
inhibited  PhIP -induced aberrant crypt formation in rats that didn’t receive DMH. 
Harris et al. (23) showed the effect of consumption of lyophilized black 
raspberries (BRB) on azoxymethane (AOM)-induced aberrant crypt foci (ACF), colon 
tumors, and urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels in male Fischer 344 
rats. The BRB were consumed at doses of 1.5, 0.75 or 0.38 g/animal/day. ACF 
multiplicity was decreased by 36%, 24%, and 21%, respectively. Adenocarcinoma 
incidences were decreased by 28-80%. The protection effect was paralleled by a 
significant reduction in urinary levels of 8- hydroxy –2’deoxyguanosine, a marker of 
oxidative DNA damage. The in vivo studies summarized above suggest a remarkable 
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1.8.3 Mechanisms 
Based on accumulating evidence that anthocyanins are chemopreventive, other 
studies have investigated the mechanism(s) of anthocyanins interference with biochemical 
activities from promotion to progression of malignancies such as those mediated by COX, 
tyrosine kinases and phosphodiesterases. Seeram et al. (109) found that cyanidin and 
malvdin showed higher COX inhibitory activities compared with commercial non-steroidal 
anti- inflammatory drugs like ibuprofen, naproxen, vioxx and celebrex.  
 
 
  Anthocyanin extracts from bilberry or purified delphidin inhibited lipid 
polysaccharide (LPS) – induced COX-2 expression at protein and transcriptional levels in 
mouse RAW24 macrophage cells. This study also demonstrated that the blockage of NF-
κB signaling pathway is involved in the inhibition of COX-2 gene expression by 
anthocyanin (69). 
Delphidin, cyandin and malvidin inhibited activity of epidermal growth factor 
receptor (EGFR) tyrosine kinase obtained from human epidermoid cells A431 with IC50 
values of 18, 42 and 61 µM respectively (110). Studies done by Marka et al. (111) 
showed that abilites of anthocyandins to inhibit EGFR tyrosine kinase in decreased in the 
order of delphidin=cyandin> pelargonidin> peonidin> malvidin. They suggested that the 
potency might be positively correlated with the hydroxyl groups in position 3’ and 5’ of 
the ring B of the anthocyanin molecule and inversely with the presence of methoxy 
groups in these positions. In contrast, the inhibition of phosphodiesterase activity in HT-
29 cells by anthocyandins demonstrated an inverse molecular structure activity 
relationship (111). Inhibitory potency in decreasing order was malvidin> peonidin> 
pelargonidin= cyanidin > delphidin. This observation suggested that phosphodiesterase 
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inhibitory potency is positively correlated with the number of methoxy moieties and 
inversely with the number of hydroxyl groups in possible 3’ and 5’ positions in the ring B 
(104).  
Anthocyanins may also affect carcinogenesis through cell cycle regulation. 
Anthocyandins from grape rinds and red rice arrested colon cancer HCT -15 cells in the S 
phase of the cell cycle (18).   Anthocyanin fractions extracted from rose petals, and red 
and white wines arrested the cells at various stages including G1, S and G2 /M phase 
(106, 112) .  Malik et al. (27) showed dual blockage at G1/G0 and G2/M phases in HT-29 
colon cancer cells by chokeberry ARE. The blockage in cell cycle was not observed in 
NCM460 normal colon cells. An additional mechanism that has been reported for 
anthocyanin inhibition of carcinogenesis is inhibition of nitric oxide (NO) production.  
NO is generated in excess during viral and bacterial infections and promotes oxidative 
stress and cancer. anthocyanins have shown strong inhibitory effects on NO production n 
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1.9. Current Study 
 
To further understand the role of anthocyanins as potential chemopreventive 
agents, commercially available anthocyanin-rich extracts (AREs) of bilberry, chokeberry 
and grape prepared for the food industry were investigated. Although some purified 
anthocyanins are commercially available, they are too expensive for animal studies. The 
advantage of using commercially prepared AREs is that unlike crude extracts of 
anthocyanin-rich foods, these extracts are produced in large volumes to have a consistent 
standardized composition.  
 Zhao et al. (26) showed that AREs from bilberry, grape and chokeberry have 
different pigment profiles, and were able to significantly inhibit growth of human colon 
cancer cells, HT-29 with little effect on growth of non-transformed colon epithelial cells, 
NCM460 (26, 27). Further investigation by Malik et al. (27) demonstrated that 
chokeberry ARE inhibited growth and cell cycle progression in colon carcinoma cells 
mainly through up regulation of p21WAF   and p27 kip1 genes and down regulation of cyclin 
A and cyclin B1 genes (27).  
The aim of the present study was to determine if these AREs would be effective 
in vivo by assessing their effect on a number of biomarkers in F344 rats treated with the 
colon carcinogen, azoxymethane (AOM). Biomarkers that were evaluated included the 
number and multiplicity of colonic aberrant crypt foci (ACF), colonic cell proliferation, 
fecal bile acids, and urinary levels of oxidative DNA damage. To assess the 
bioavailability, levels of anthocyanins in serum, urine and feces were evaluated. The 
specific anthocyanins and anthocyanin metabolites detected in these samples are reported 
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in the paper by He et al. (113). We further wanted to determine if the in vivo mechanisms 
of action would be similar to those observed in the human cell lines by evaluating the 
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Chapter 2. Materials and Methods 
2.1. Chemicals and Materials 
Food grade AREs of bilberry (Vaccinum myrtillus L.) and chokeberry (Aronia 
meloncarpa E.) were supplied by Artemis International, Inc. (Fort Wayne, IN). Grape 
(Vitis vinifera) extract was supplied by Polyphenolics, Inc. (Madera, CA). AOM was 
obtained from Sigma Chemical (St. Louis, MO).   
 
 
2.2 Measurement of ARE Properties 
2.2.1. Monomeric Anthocyanin Content and Total Phenolics. The monomeric 
anthocyanin content of extracts was determined by pH-differential method (114). A 
Shimadzu 1601 UV spectrophotometer (Shimadzu Scientific Instruments, Inc., Columbia, 
MD) and 1 cm path length disposable cuvettes were used for spectral measurements at 
520 and 700 nm. Pigment content calculation was done as cyanidin-3-glucoside, using 
extinction coefficient (ε) of 26900L cm-1 mol-1 and molecular weight (MW) of 449.2 g 
mol-1. The anthocyanin profiles of these extracts have been previously reported (26).  
Total phenolics were measured by the Folin Ciacalteau method as described (26). The 
absorbance of the samples and standards was measured at 755 nm. Total phenols were 
calculated as gallic acid equivalents based on a gallic acid standard curve. 
 
2.2.2. Oxygen Radical Absorbance Capacity (ORAC) Values.  The ORAC values for 
AREs was measured based on procedure described by Prior and coworkers (115).  The 
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automated assay was carried out on the COBAS FARA II centrifugal analyzer (Roche 
Diagnostic System Inc., Branchburg, NJ) with fluorescence detector.  Trolox (6-hydroxy-
2,5,7,8-tetramethylchroman-2-carboxylic acid)  was used as a control antioxidant 
standard. R-phycoerythrin (R-PE) was used as a target of free radical attack with 2,2’- 
azobis (2-aminopropane) dihydrochloride (AAPH) as a peroxyl radical generator. The 
analyzer was programmed to record the fluorescence of R-PE every 2 min after addition 
of AAPH. The final ORAC values were calculated using a differences of areas under the 
quenching curve of R-PE decay curves between a blank and a sample expressed as 
micromoles of Trolox equivalents per g of compound. 
. 
 
2.3. Animal and Experimental design 
2.3.1. Preparation of Diets.  Control diet was AIN-93 powdered diet (Dyets Inc., 
Bethlehem, PA). Diets containing 3.85g/kg monomeric anthocyanin from chokeberry, 
bilberry or grape ARE were prepared by supplementing AIN-93 powdered diet at the 
expense of cornstarch. All the three anthocyanin-rich extracts were added on the basis of 
their monomeric anthocyanin content (Table 1).  All diets were prepared fresh on a 











Table 1: Diet Composition  
Ingredient 
gm/kg 
AIN-93 AIN-93 with 5% 
Chokeberry ARE 
AIN-93 with 3.5% 
Bilberry ARE 
AIN-93 with 2.6% 
Grape ARE 
Casein 200 200 200 200 
L-Cystine 3.0 3.0 3.0 3.0 
Sucrose 100 100 100 100 
Corn starch 397.486 347.486 362.486 370.986 
Soybean oil 70 70 70 70 
Fiber (cellulose) 50 50 50 50 
Mineral Mix 35 35 35 35 
Vitamin mix 10 10 10 10 
Choline bitartrate 2.5 2.5 2.5 2.5 
AREs - 50 35 26 
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2.3.2 Animal Treatment and Housing.  Forty 3-4 week old male specific pathogen free 
F344 rats were obtained from Harlan (Indianapolis, Indiana). In the first week of 
acclimatization, rats were slowly weaned from pellet rat chow to powdered AIN-93 diets. 
Chewing bones (Bio-Serv, Frenchtown, NJ) were also provided to prevent overgrowing 
teeth due to feeding of a powdered diet.  Rats were randomly allocated in four groups of 
ten animals each. The animals were housed in pairs in suspended stainless steel cages 
with wire mesh floor and front. Powdered diet was provided in standard feeding cups.  
Diet and tap water was available ad libitum. Artificial light was supplied from 
fluorescent tubes, in a 12 h light –12 h dark cycles.  Relative humidity was maintained at 
25% - 60%. Health signs were monitored daily and clinical signs for all the animals were 
recorded weekly. All animals randomly received one dose of a subcutaneous injection of 
AOM in saline at a dose of 20 mg/kg.  
Body weight was recorded twice every week and food intake was recorded twice 
for 3 days/cage during the 14 weeks study.  All animal experiments were conducted in 
accordance with U.S. Animal Welfare Act and U.S. Public Health Service Policy. The 
University of Maryland Institutional Animal Care and Use Committee (IACUC) 
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2.4. Sample Collection 
2.4.1. Urine and Feces Collection.  One week before the end of the study, samples of 
urine and feces were collected from eight animals randomly selected from each group. 
Each animal was placed individually in nalgene metabolic cages (Mini Mitter Inc., Bend, 
OR).  The powdered diet was not provided during this time to reduce any contamination 
of urine by diet spillage. Urine samples were collected during the dark cycle every 6 hrs 
for 12 hrs and divided equally into eppendorf tubes. To one set of samples, 20% 
trifluoroacetic acid (TFA) was added to preserve anthocyanins prior to freezing at -80°C. 
Fecal samples were collected at the end of 24 hrs and weighed. A portion of each sample 
was analyzed for moisture content and remaining was frozen at -80°C for further use. 
 
2.4.2.Tissue and Blood Collection. To collect blood, light anesthesia by CO2 exposure 
was used prior to decapitation. This was done to reduce stress in animal and enhance 
safety of personnel/ the researcher. Blood was collected into 10ml tubes without heparin 
and after clotting, the blood samples were ringed and centrifuged at 10,000g for 10 min at 
room temperature.  The serum samples were quickly divided into several eppendorf 
tubes.  To one aliquot, 20% TFA was added to preserve anthocyanins and to precipitate 
proteins. This sample was centrifuged for 5 min at 3000 rpm at 4°C prior to freezing at -
80°C.  
Colons were flushed with ice-cold saline to remove fecal material. The colon was 
slit open longitudinally and the proximal 4 cm was immersed and fixed in RNAlater 
(Ambion Inc., Austin, TX) for RNA isolation. The remaining colon was fixed in 10% 
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buffered formalin for evaluation of ACF and cell immunohistochemistry. Other tissues 




2.5. Biomarkers Evaluated 
2.5.1. Fecal Moisture Content. Fecal pellets were well formed and diarrhea was not 
observed but visual observation suggested that feces from animals on ARE diet were 
distinctive from rats on control diet. The feces were moist and appeared darker and 
larger. This led us to measure the fecal wet weight and fecal dry matter by oven-drying 
method (105°C until weight constancy). 
 
2.5.2. Fecal bile acids. Bile acids in freeze-dried feces were assayed by the method as 
described by Romero et al. (116) t-butanol/water (1:1) (4 mL) was added to 0.2 g freeze-
dried fecal samples. The samples were homogenized and incubated for 15 min at 37◦C 
with continuous shaking. The samples were centrifuged at 3000g for 10 min. and the 
supernatant was removed for analysis of total bile acid content by a enzymatic recycling 
method using total bile acid assay kit (Diazyme Laboratories, La Jolla, CA). Each sample 
was analyzed in at least duplicate. 
 
2.5.3. Aberrant Crypt Foci.  ACF were evaluated as previously described (117). ACF 
were highlighted by staining the colons with 0.1% methylene blue in PBS and identified 
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using light microscope at 40X magnification. Number, multiplicity (number of crypts per 
focus) and distribution of ACF were recorded.   
 
2.5.4.  Anthocyanin Profiles. The anthocyanin profiles of the AREs used in this study 
have been reported previously (26).  In this study, the presence and concentration of 
anthocyanins were measured in the serum, urine and feces of rats. 
Sample preparation. Analysis of urine and serum anthocyanin was performed as 
previously described (118). The urine and serum samples were applied to 6cc C18 Sep-
pak cartridges (Waters Corp., Milford, MA) preconditioned with 5 ml methanol 
containing 1% TFA followed by 5ml 1% aqueous/TFA solution to remove the methanol. 
Loaded cartridges were washed with 5ml 1% aqueous/TFA solution, and anthocyanins 
eluted with 5ml 1% methanol/TFA solution. The elutant was evaporated, dissolved in 
aqueous 1% TFA solution and filtered through 0.45 µm polypropylene filters (Whatman 
Inc., Clifton, NJ). Fecal samples were prepared according to the procedure of He and 
colleagues (113, 119). Samples were ground to a powder and 0.1 g of feces extracted 
with 20 ml of methanol:water (60:40 v/v) solution containing 1 % TFA. Samples were 
homogenized and sonicated for 10 min. After centrifugation (3500 rpm, 15 min) the 
supernatant was removed and the pellet reextracted with 10 ml of the same solvent.   
Combined supernatants were diluted with acidified water and applied to a C18 
cartridge. To remove polar lipids, the column was washed with 5 ml of aqueous 1%TFA 
solution followed by a wash with 3 ml of dichloromethane/1%TFA solution. To further 
remove polar and neutral lipids, the column was washed with 3mL of hexane/1%TFA 
(benzene) and ethylacetate/1%TFA solution respectively. Anthocyanins were eluted from 
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the C18 column as described for urine and serum samples and 300 µl injected into the 
HPLC. 
High Pressure Liquid Chromatography.  A Waters Delta 600 HPLC equipped with a 
Waters 996 photodiode array detector, a Waters 717 plus autosampler, and Millenium 32 
software (Waters Corp.) was used for analyses of anthocyanins. The mobile phase was 
composed of the following solvents: A- 1% phosphoric acid, 10% acetic acid, 5% 
acetonitrile, 84% water, and B- 100% acetonitrile. Solvents and samples were filtered 
though a 0.45 µm polytetrafluoroethylene membrane filters (Pall Life Sciences, Ann 
Arbor, MI) and 0.45 µm polypropylene filters (Whatman Inc.), respectively. 
The gradient system used for all samples was: 0-5 min 100% isocratic, 5-40 min 
linearly decrease to 65% A, 40-45 min linearly increase to 100% A. For quantification 
the total peak area under the peak at 520 nm was calculated. By comparing external 
standard of cya-3-galactoside, the peak area was converted to anthocyanin concentration 
expressed as cya-3-galactoside.  
 
2.5.5. Measurement of Urinary 8-OHdG.  Urinary 8-OHdG was measured using the 
Enzyme-linked Immunosorbent Assay (ELISA, Genox Corporation, Baltimore, MD), to 
assess the ability of the three ARE diets to reduce oxidative DNA damage.  As there was 
variation in the total amount of urine collected from different rats, urine creatinine 
concentrations were measured. Analysis was performed using a creatinine colorimetric 
microplate assay kit (Oxford Biomedical Research Inc. Oxford, MI) according to the 
manufacturer’s protocol.  
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2.5.6. Cyclooxygenase-1 and -2 mRNA Levels Expression.  Changes in mRNA levels 
expression of cyclooxygenase genes were analyzed as described earlier (27).  In brief, 
total cellular RNA was extracted from colonic mucosa lining using Trizol reagent 
(Invitrogen, Carlsbad, CA). Human COX-1 and COX-2 gene-specific Relative RT-PCR 
Kits (Ambion Inc.) were used with ribosomal gene 18S (498 bp) as an internal control. 
The following thermocycling conditions were used for PCR assays: one 2-min cycle at 
920C followed by 26 cycles of denaturation for 30 s at 920 C, annealing for 30 s at 590C 
(COX-1) or 30 s at 600C (COX-2), and extension for 1 min at 720C. The final extension 
was given for 5 min at 720C.   The PCR products from multiplex reactions were analyzed 
using DNA LabChip® and Agilent 2100 bioanalyzer according to the manufacturer’s 
protocol. The changes in the gene expression were represented by the changing ratio 
between the area of bands representing gene of interest and the band representing 18S 
gene.  
 
2.5.7. Cell Proliferation Measurements.  Colonic cell proliferation was measured using 
PCNA immunohistochemistry as described previously (117) with slight modifications. 
Following quenching of endogenous peroxidase activity, slides were incubated with 
Dako Protein Block Serum Free (DakoCytomation, Carpinteria, CA) and mouse 
biotinylated PCNA monoclonal antibody clone PC10 at 1:200 dilution (Invitrogen, 
Carlsbad, CA). To visualize crypts, a light Mayer’s hemotoxylin counter stain was used.  
 
2.5.8. Data analysis.  One-way analysis of variance (ANOVA) was conducted for the all 
data analyses using SAS software (8.1, SAS Institute Inc, Cary, NC) to determine if there 
   - 39 -  
were significant differences between rats fed ARE and control diets.  ANOVA with 
repeated measures was done to determine the significant difference in body weight. 
Duncan’s test was used for multiple mean comparisons when the ANOVA was 
significant.   
Chapter 3. Results  
3.1. Food Consumption and Rat Body Weight.  
There was no significant difference (p>0.05) in food consumption or body 
weights among groups throughout the 14-week study (Figure3). Average food 
consumption was 17 grams/day. Based on the average body weight of the rats and 
anthocyanin and phenolics concentrations in the diet, rats consumed approximately 26 
mg anthoycanin/kg/day and 80 mg phenolics/kg/day. No adverse clinical signs were 
observed during the study.  
 
3.2. Extract and Diet Characteristics.   
Grape ARE had the highest percentage of monomeric anthocyanin (14.7%) and 
total phenolics (43.2%) followed by bilberry with 11.0% and 32.6%, and chokeberry 
ARE with 7.7% and 32.9%, respectively (Table 2).  Grape ARE also had a higher ORAC 
value than bilberry and chokeberry ARE (Table 2). To achieve equal amount of 
anthocyanin per gram of diet, different amounts of ARE extracts were added to the diet at 
the expense of cornstarch. The resultant calculated total phenolics and ORAC values for 
the diets are shown in Table 2.  
 
 



























Figure 3. Average body weights of rat  fed ARE or control diet. Values are the mean ± 
SEM of 10 rats per group.  
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Table 2: Total monomeric anthocyanin content, phenolic content and antioxidant activity 









 (µmol TE/g) 
Bilberry 11.0 32.6 3042.9 
Chokeberry 7.7 32.9 3388.0 




          (mg/g) 
Total phenolics  
(mg/g) 
ORAC 
 (µmol TE/g) 
Bilberry   0.385  1.143 1.065 
Chokeberry  0.385  1.645 1.694 
Grapes 0.385  1.132 1.122 
 
a data expressed as milligrams of cyanidin-3 glucoside equivalents per gram of  extract 
b data expressed as milligrams of gallic acid equivalents per gram of extract 
c data expressed as micromoles of trolox equivalents per gram of fresh weight 
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3.3. Aberrant Crypt Foci.  
ACF were present in all animals. The total number of ACF was significantly 
(p<0.05) decreased in the colons of rat fed bilberry, chokeberry and grape ARE diets 
when compared to rats fed the control AIN-93 diet (Table 3). Large ACFs (≥ 5 
multiplicity) were significantly reduced in rats fed bilberry ARE (p=0.0003), and 
chokeberry ARE (p=0.002) as compared to grape ARE or control group. Rats fed 
bilberry ARE had a striking 70% reduction in large ACF compared to controls.  The 
number of medium ACFs (4-5 multiplicity) in bilberry (p=0.005) and grape (p=0.02) fed 
groups was significantly lower compared to either chokeberry (p=0.08) or control AIN-
93 group. No significant difference (p>0.05) was observed among the small ACFs (2-3 
multiplicity) among all groups. Most ACF were found in the distal portion of the colon 
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Table 3: Effect of AREs on total ACF and different categories of ACF multiplicity  
Diet group Total       
  
Small (2-3)  Middle (4-5)   Large >5  
AIN-93 (Control) 94 ± 12.2 a  
 
46 ± 6.0 33 ± 4.9 15 ± 3.0 a  
Bilberry 67 ± 9.1 b 43 ± 7.1 19± 2.8 4 ± 0.7 b
 
Chokeberry 70 ± 3.5 b 39 ± 2.8  25 ± 1.8 6± 1.4 b  
 
Grape 69 ± 6.2 b 35 ± 4 .3 22 ± 2.3 11±1.7 a  
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3.4. Anthocyanin Concentrations in Animal Samples.  
3.4.1 Urine. Anthocyanins were not detected in the urine of control rats, whereas 
anthocyanin peaks were observed in urine of all rats on the ARE diets at 520 nm (data not 
shown). Significant differences (p=0.002) were observed in the concentration of total 
monomeric anthocyanins among urine samples from bilberry, chokeberry and grape 
ARE-fed rats varying from 23.6 mg cy-3-gal/L urine in chokeberry ARE-fed rats to 7.8 
mg/L in bilberry ARE-fed rats (Figure 4A). 
 
3.4.2 Feces. The total monomeric anthocyanin concentrations in fecal extracts varied 
from 2.0 mg/L in bilberry ARE fed rats to 0.7 mg/L in grape ARE fed rats (Figure 4B). 
Bilberry and chokeberry ARE-fed rats had higher fecal anthocyanin concentrations as 
compared to grape ARE-fed rats (p=0.029). Anthocyanin specific peaks were not 
detected in the fecal extracts of rats on control diets. 
 
3.4.3 Serum. Anthocyanins were detectable but below quantifiable levels in serum 
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Fig. 4B. Total anthocyanins concentration in fecal extracts from rats fed ARE or control 
diet. Values are the mean ± SEM of n=7 for chokeberry and grape fed rats, n=5 for 
bilberry fed rats. Bars with different letters are significantly different at p < 0.05. 
Anthocyanins were not detected (n.d.) in feces of rats fed the control diet. 
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3.5. Fecal Moisture Content.  
 During the experiment, we observed that rats on ARE diets had larger feces. To 
determine whether the increase in the size was due to increased moisture content or 
increased fecal content, the moist and dry fecal weight from 24 hr collections at two 
different times were determined. As observed in Table 4, the moisture content of feces 
from ARE-fed rats was significantly higher than for control diet rats. Dry weight of feces 
was also significantly higher in rats fed both bilberry and grape ARE as compared to 
controls.  
 
3.6. Fecal Bile Acids.  
The concentration of total bile acids in fecal extracts was dramatically reduced 
from 385 µmol/L in control rats to 133 - 68 µmol/L in ARE-fed rats (Table 5). As the 
amount of feces excreted per day was increased in ARE-fed rats (Table 5), fecal bile acid 
values were converted to µmol/g feces and multiplied by the individual fecal output to 
determine if the ARE-diet altered the total daily bile acid excretion. The daily  (24 hour) 
fecal excretion of bile acids in ARE fed-rats ranged from 0.5 to 2.0 µmol/day compared 










Table 4:  Effect of feeding AREs diets on 24-hour fecal collections   
Diet group Fecal weight (g/day)  Fecal dry weight (g/day) Fecal moisture content (%) 
Control 0.63 ± 0.07 a 0.38 ± 0.04 a 39.2 ± 0.97 a  
Bilberry 1.39 ± 0.17 b 0.69 ± 0.07 b 48.9 ± 0.96 c
Chokeberry 0.86 ± 0.10 a 0.42 ± 0.04 a 49.3 ± 1.68 c
Grape 1.32  ± 0.16 b 0.71  ± 0.07 b 45.1 ± 0.99 b
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        Table 5:  Effect of feeding ARE diets on fecal bile acids concentration in 24-hour fecal collections  
 
Diet group Bile acids in fecal 
extract (µmol/L) 
Bile acid concentration 
(µmol/g dry feces) 
Total fecal bile acids 
(µmol/g day) 
Control (n=5) 385.1 ± 111.4a 7.70 ± 2.23 a 2.68 ± 0.65 a  
Bilberry (n=5) 67.7 ± 10.8 b 1.35  ± 0.22 b  1.26 ± 0.31 b c  
Chokeberry (n=5) 83.2 ± 15.6 b 1.67 ± 0.31 b  0.55 ± 0.10 c  
Grape (n=6) 133.1 ± 28.4 b 2.66 ± 0.57 b  2.00 ± 0.51a b  
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3.7. Urinary 8-OHdG Determination.  
 Urinary 8-OHdG is widely used as a measure of oxidative damage of DNA. 8-OHdG 
reflects DNA mutation potential (120). There was no significant difference in urinary 8-
OHdG levels among any of the groups. Adjusting for urine creatinine levels did not 
change the results. 
 
3.8. Cyclooxygenase mRNA. 
 The COX-2 gene mRNA levels were down regulated in colonic mucosa of rats fed 
bilberry and grape ARE diets compared to rats fed either control or chokeberry ARE diet 
(p=0.009) (Figure 5). COX-2 m-RNA levels expression in chokeberry ARE-fed rats did 
not differ from control rats (Figure 5). No significant difference was observed in the 
expression of COX-1 gene in the colonic mucosa among groups. 
  
3.9. Colonic Cell Proliferation.  A significant decrease in colonic cell proliferation in 
rats fed bilberry ARE (p=0.008) and chokeberry ARE (p=0.015) diets, compared  
to rats fed the control diet (Table 6).  Rats fed grape ARE diet showed no change in the 
cellular proliferation compared to controls (Table 6). However, there was no significant 
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Table 6:  Colonic crypt height and proliferation index of rats fed anthocyanin-rich or control diet 
Diet group Crypt height Proliferation index 
AIN-93 (Control) (n=10) 31.7 ± 0.74  23.6 ± 2.85 a
Bilberry (n=5) 31.2 ± 0.54  12.1 ± 2.01 b
Chokeberry (n=5) 29.7 ± 1.24  16.0 ± 2.82 b
Grape (n=5) 32.7 ± 0.38 22.1 ± 3.02 a
ab Mean (mean ±SE) with different letters are significantly different at P < 0.05. 
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Chapter 4. Discussion 
 
We report significant reduction of several biomarkers of colon cancer by dietary 
AREs in the azoxymethane animal model, providing in vivo confirmation of the 
chemopreventive activity observed in vitro in HT29 colon cancer cell line studies (26, 
27). This in vivo study also identified multiple mechanisms for the chemopreventive 
activity of AREs, including several mechanisms of action predicted by cell lines studies. 
In addition, we report for the first time, that dietary AREs significantly alter the 
composition of the colonic contents resulting in a protective effect against colon 
carcinogenesis.  
Rats on ARE diets had significantly fewer colonic ACF when compared to the 
control group, indicating that all three extracts may have chemopreventive activity. ACF 
are preneoplastic lesions of colon cancer (38, 121) widely accepted as a biomarker for 
risk of colon cancer development (37) . Rodent ACF, induced with chemical carcinogens 
such as AOM, have been utilized for screening chemopreventive agents (122)  and also 
for risk assessment of chemicals (123). ACF rarely occur in untreated rats (117,124) but 
appear in colon and rectum within few weeks during post initiation phase after treatment. 
Quantification of these lesions in humans has recently been reported using magnifying 
endoscopies (119,125) and these lesions are being utilized as endpoints for 
chemoprevention trials.   
The aberrant crypts of higher multiplicity, multicrypt foci, are a more consistent 
predictor of tumor outcome than the number of ACF (38, 126, 127). Rats fed bilberry 
   - 54 -  
ARE had 70% fewer large ACF compared to rats fed the control diet, indicating 
significant chemoprevention. Chokeberry-fed rats had a 59% reduction in large ACF, 
whereas the reduction was only 27% in rats fed grape ARE. The type and number of 
glycosylations in the anthocyanins in these three extracts varied greatly, which markedly 
affected absorption as discussed in our report on the anthocyanin profiles of the plasma 
and urine samples from the rats in this study  (113, 128).  Others have reported inhibition 
of ACF and colonic tumors by addition of anthocyanin-rich extracts (24, 25) and 
anthocyanin-rich freeze-dried black raspberries (23). Anthocyanins isolated from tart 
cherries inhibited cecal adenomas but not colonic tumors in ApcMin mice (22). The AREs 
used in this experiment contained not only anthocyanins, but also other phenolics. 
Although the chokeberry diet contained a higher amount of total phenolics, rats fed the 
chokeberry diet had similar ACF growth as rats fed the bilberry diet, suggesting 
inhibition did not depend on difference in total phenolics. These results are in agreement 
with our cell line work (26). 
Greater inhibition of cell proliferation in rats fed bilberry and chokeberry AREs 
also agrees with our cell line studies in which greater inhibition of HT29 cell growth was 
observed with these extracts as compared to grape ARE.  Zheng and coworkers (129) 
observed a correlation between the ability of retinoids to prevent ACF and decrease in 
PCNA labeling index. We reported that chokeberry ARE blocks HT29 cells at the G1/G0 
and G2/M phases of the cell cycle, which coincided with increased expression of p21 and 
p27 genes, and decreased cyclin A and B gene expression (27).  Although Lazze and 
coworkers (130) also reported that anthocyanins induced cell cycle blockage in CaCo2 
and HeLa cells, their studies were conducted with anthocyaninadins, the aglycones of 
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anthocyanins, rather than with anthocyanins.  Aglycone compounds are rarely, if ever, 
found in natural food components (131).  Although deglycosylation of anthocyanins to 
aglycones by intestinal bacteria was initially suspected, direct absorption of glycosylated 
anthocyanins has been well documented (80, 118, 132), and aglycones are considered 
unstable at physiological pHs (79, 118). Hence, the findings of Lazze and coworkers 
(130) are not supportive of the effects of food-based anthocyanin extracts.  Kang et al. 
(22) reported inhibition of cell proliferation in HT29 and HCT116 cells as a potential 
mechanism for the inhibition of intestinal tumors by tart cherry anthocyanins observed in 
APCmin mice. However, to our knowledge, this is the first report of inhibition of cell 
proliferation by AREs in vivo.  
To determine if the antioxidant activity of the three extracts may have a role in 
their anticarcinogenic activity, we measured the ORAC values of the AREs and diets.  
The ORAC value of grape ARE was comparable to freeze-dried skins of highly 
pigmented red wine grapes (133).  The chokeberry ARE ORAC value was 21 times 
higher than reported for wild fruits (134).  Bilberry ARE had 23-161 times higher ORAC 
value compared to that reported from fresh bilberry fruit samples (135 ).  Despite the high 
ORAC values, we found no effect of the ARE diets on urinary 8-OHdG levels.  This is in 
contrast to Harris et al. (23) who reported significant reduction in urine 8-OHdG levels in 
rats treated with azoxymethane and fed freeze-dried black raspberries.  The difference 
may be attributed to stage of carcinogenesis during which urine is collected.  In our 
study, urine was collected from rats at the ACF stage, whereas the study by Harris (23) 
was longer-term and rats had advanced colonic tumors at the time of urine collection. 
Although we did not obtain evidence of an antioxidant effect of AREs in vivo, increased 
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serum antioxidant activity following consumption of anthocyanins has been reported 
(115).  Perhaps serum antioxidant levels may have been a better parameter to measure in 
this study than urinary 8-OH deoxyguanosine.  However, in our study, all serum was 
used for anthocyanin analyses.  
One observation to note is that although bilberry diet had the lowest ORAC value, 
it was the most effective in inhibiting large ACF development and cell proliferation.  This 
suggests that antioxidant activity of anthocyanin-rich extracts, as measured by ORAC, is 
not directly predictive of in vivo chemoprotective activity.  Similarly, Lui and colleagues 
(136) reported that the total antioxidant activity of various raspberries was not correlated 
with their ability to inhibit the growth of HepG2 cells..   
 Inhibition of COX-1 and COX-2 enzymes has been demonstrated by anthocyanins 
from different berries including tart cherries, raspberries and blackberries (137, 138).  
Seeram et al. (138) demonstrated that cyanidin-3-glucosylrutinoside and cyanidin-3-
rutinoside, anthocyanins from raspberries and sweet cherries inactivate COX-1 and COX-
2 enzymes in vitro.  However, we found that in the HT-29 cells, chokeberry ARE had a 
very transient inhibitory effect on COX-2 mRNA levels with no effect on COX-2 protein 
or prostaglandin E2 levels (27).  In this study, rats fed bilberry and grape ARE, but not 
chokeberry, demonstrated a decreased expression of COX-2 mRNA levels.  
Epidemiological and preclinical studies have shown that several nonsteroidal anti-
inflammatory drugs (NSAIDs), which inhibit the COX-2 gene and enzyme, can reduce 
ACF and colon cancer both in animals and humans (139).  However there is considerable 
concern about their adverse effects, which can be occasionally severe and life 
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threatening, and are at least partly attributed to inhibition of COX-1.  None of the ARE 
diets inhibited COX-1 gene expression, and inhibition of COX-2 may have contributed to 
the chemopreventive activity of the bilberry and grape ARE diets.  
  
One of the questions that arise when considering anthocyanin extracts as potential 
chemopreventive agents is the degree to which these compounds are bioavailable.  To 
address this question, we measured the concentration of anthocyanins in serum, urine and 
feces.  Cancers of the gastrointestinal tract are unique in that even compounds that are not 
absorbed can have direct contact with cells.  As has been reported by other researchers 
(72, 118) serum of rats fed AREs contained only very low levels of anthocyanins (below 
the level of quantitation).  However, the presence of anthocyanins in urine indicated that 
absorption did occur.  We report for the first time, that high amounts of anthocyanins 
were found in the intestinal contents. Indeed, rats fed the bilberry and chokeberry 
extracts, had the fewest ACF and the highest fecal anthocyanin concentrations, 
suggesting that the chemopreventive activity of anthocyanins may be not via absorbed, 
but rather via unabsorbed anthocyanins.  This hypothesis is supported by the observation 
that anthocyanin-rich diets have been effective in prevention of cancers in animal studies 
in the oral cavity, the esophagus (140), and colon (22-25) but not lung cancer (141).  
In a review of mechanisms of colon cancer prevention (142), three mechanistic 
groups of agents were described: (1) agents that are confined to the intestinal lumen and 
function to reduce irritation of epithelium; (2) agents that inhibit COX2 and reduce 
inflammatory responses; and (3) agents that are antioxidants and reduce damage by 
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reactive oxygen intermediates.  The data from this study suggest that AREs may be 
agents that act by all of these mechanisms.  Rats fed the ARE diets had significantly 
increased fecal bulk and fecal moisture compared to rats fed the control diet.  The 
increased fecal moisture content and fecal bulk would reduce the concentration of 
endogenous tumor-promoting compounds such as bile acids in the colon resulting in less 
irritation and this may have also contributed to the reduction in cell proliferation.  In 
rodent models, bile acids have been well established as promoters of colon cancer (38, 
143).  Recently bile acids have been proposed as colon carcinogens in humans (54).  
Reduction of levels of fecal bile acids and fatty acids by dietary means such as calcium 
supplementation and high fiber diets is considered to be chemopreventive because the 
reduction of cytoxicity of the aqueous phase of the colonic contents is associated with a 
reduction of proliferative markers (144).  Poly ethylene glycol 8000 (PEG), a highly 
effective colon chemopreventive agent, increased fecal bulk and reduced the bile acid 
concentration in feces of PEG- fed rats but the daily fecal excretion of bile acid was same 
as controls (145).  In the present study, the concentration of 7.7 µmol bile acids/g dry 
feces in rats fed the control diet was similar to the levels of 3.3 µmol/g fresh feces 
reported by Corpet and Parnaud (1999) when the difference in moisture content is 
considered.  ARE-fed rats showed a dramatic 65-82% reduction in the bile acid 
concentration in feces, and, unlike PEG, the daily total fecal excretion of bile acids was 
also reduced.  The decrease in total bile acid concentration in feces with dietary 
supplementation of AREs indicates that reduced gastrointestinal irritation may be 
responsible for the decrease in cell proliferation as observed with PCNA 
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inmmunohistochemistry.  Further investigation is required to establish the mechanism by 
which dietary AREs reduce fecal bile acids. 
Chapter 5. Conclusion and Future research 
In conclusion, the present in vivo study in F344 rats demonstrates that 
anthocyanin rich extracts from bilberry, chokeberry and grape significantly inhibited 
ACF formation induced by AOM.  Our results clearly support the chemopreventive 
activity of these extracts reported in previous in vitro studies (26, 27).  We have also 
conducted detailed analyses of the anthocyanins found in the serum, urine and feces as 
compared to the anthocyanins in the diets fed to the rats in this study (113, 128).  These 
data indicate that the structure of the anthocyanins, specifically the degree of 
glycosylation, affects the degree to which the anthocyanins will be absorbed and excreted 
in the feces. 
  High levels of anthocyanins in the intestinal contents appear to act both directly 
on cells lining the gastrointestinal tract, and indirectly by altering the gastrointestinal 
environment to be less damaging to the mucosal surface. These data suggest that 
anthocyanins may play a significant role in prevention of gastrointestinal cancers by 
fruits and vegetables. Furthering our understanding of the effect of structure of 
anthocyanins on uptake and excretion will improve our ability to develop optimal 
anthocyanin profiles for chemoprevention of cancers of the gastrointestinal tract.   
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